Latest updates for Galzus Research

Fresh curated links around Galzus Research are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Immuneering Corporation: Updates Inbound At The End Of The Month
  • Maralixibat Improves Xanthomas and Hypercholesterolemia in Children with Alagille Syndrome: A Post Hoc Integrated Analys
  • Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /2 weeks ago

Immuneering Corporation: Updates Inbound At The End Of The Month

Read source
jpeds.com /1 month ago

Maralixibat Improves Xanthomas and Hypercholesterolemia in Children with Alagille Syndrome: A Post Hoc Integrated Analys...

To characterize baseline xanthoma prevalence and severity in Alagille syndrome, assess their impact on quality of life, evaluate longitudinal changes in xanthoma burden with marali...

Read source
seekingalpha.com /1 month ago

Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow

Read source
amrc.org.uk /1 week ago

Glaucoma UK Impact Report 2025

Type of impact: Knowledge creation (publications); tools and methods (biorepository, tool kits); dissemination (engagement activities); collaborations; supporting researchers (earl...

Read source
news.samsung.com /3 days ago

Samsung and Massachusetts General Hospital Launch Joint Study To Investigate GLP-1 Treatment Monitoring With Galaxy Watc...

Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly announced a research study to investigate the efficacy of Galaxy Watch in...

Read source
kidney-international.org /1 month ago

Pegcetacoplan Prophylaxis for Recurrent C3 Glomerulopathy with Multifactorial Genetic Background

A 9-month-old female infant with no family history of kidney disease was admitted in 2014 for macroscopic haematuria. Laboratory tests showed normal renal function (eGFR sec. Schwa...

Read source
genengnews.com /1 month ago

Hydrogel-Based Axon Model Improves Early Testing for MS Remyelination Therapies

The team engineered vertical micropillars—each tens of times thinner than a human hair—using a microfabrication process called photolithography that allowed them to precisely tune...

Read source
youthkiawaaz.com /3 weeks ago

Reliability And Testing Of AOD 5MG In Laboratory Models

Scientific breakthroughs are never the result of guesswork; they are the product of rigorous methodology and verified materials. In the study of metabolic health, the use of target...

Read source
bioengineer.org /1 month ago

Gmppb Mutation Rescued by GSK3β Inhibition or Gene Therapy

In a groundbreaking study poised to redefine therapeutic strategies for muscular dystrophies, a team of researchers led by Fu, Wang, and Zhang have unveiled compelling evidence tha...

Read source
lifespan.io /2 weeks ago

Current Clinical Trials of Alzheimer’s Drugs

This month, a group of researchers published an annual report on the clinical trials that are testing drugs for Alzheimer’s disease. Overall, they reported an increase in the numbe...

Read source
newswire.com /1 month ago

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hosp...

Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage regeneration expert Prof. Elizaveta Kon to help lead Regentis C...

Read source
bioengineer.org /3 weeks ago

Alkali-Ion Enhanced Zeolitic Imidazolate Glasses

In a groundbreaking advancement that could reshape the future of materials science, researchers have uncovered new insights into the realm of zeolitic imidazolate framework (ZIF) g...

Read source
urdu.arynews.tv /2 weeks ago

میٹا اسمارٹ گلاسز سے نجی زندگی متاثر ہونے کا انکشاف، تحقیقات کا آغاز

نیروبی : ٹیکنالوجی کمپنی میٹا کے رے بین اسمارٹ گلاسز نے نئے مسائل پیدا کردیے، کینیا نے ان گلاسز کے خلاف رازداری (پرائیویسی) خدشات کے پیشِ نظر تحقیقات کا آغاز کردیا گیا ہے۔ کینیا کے...

Read source
gastrojournal.org /4 weeks ago

157 CLINICAL POTENTIAL OF BLOOD SAMPLE-BASED DIAGNOSTIC TEST FOR BILE ACID DIARRHEA

Read source
multiplesclerosisnewstoday.com /1 month ago

AAN 2026: GA Depot may help stabilize disability in RMS and PPMS

Mapi Pharma’s long-acting formulation of glatiramer acetate, GA Depot, may help stabilize disability scores over time in people with both relapsing forms of multiple sclerosis (MS)...

Read source
newswire.com /2 weeks ago

IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference

Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, patient stratification, and future therapeutic development.

Read source
bioengineer.org /1 week ago

Targeted Therapy Advances in H3K27-Altered Glioma

In an era where cancer research continually pushes the boundaries of personalized medicine, a groundbreaking study has emerged, promising newfound hope for patients suffering from...

Read source
gastrojournal.org /1 week ago

Bridging Genetics and Bedside Decisions in IBD: Utility Metrics for Susceptibility PGS

Read source
cafepharma.com /13 hours ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
seekingalpha.com /2 days ago

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript

Read source
bioengineer.org /1 month ago

Small Molecule Drug Candidate Completely Restores Survival in Lethal Mouse Model of Rare Kidney Stone Disease with No Ex...

A groundbreaking discovery from the Buck Institute for Research on Aging may soon rewrite the medical landscape for patients suffering from Primary Hyperoxaluria Type 2 (PH2), an a...

Read source
gastrojournal.org /4 weeks ago

159 IMPAIRED CA2+ WAVE PROPAGATION UNDERLIES GALLSTONE DISEASE IN MICE FED A LITHOGENIC DIET

Read source
journals.plos.org /1 month ago

Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomizat...

by Guoqiang Li, Fu Jianhan, Jiashu Gu, Yinhuai Wang, Jiachen Liu, Dong Yang, Dianjie Zeng, Pengcheng Zhao Glomerulonephritis (GN) is an immune-mediated kidney disorder that causes...

Read source
pharmexec.com /2 days ago

<![CDATA[Changing the Standard of Care for Lupus Treatment: Q&A with Albert T. Roy]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Galzus Research

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source